Skip to content

Impact of Antimicrobial Stewardship Programs in the Global Setting

Partnership to Enhance Antimicrobial Use in Resource-Limited Settings (PEARL): An Assessment of Need and Feasibility of Antimicrobial Stewardship Programs

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03382470
Acronym
PEARL
Enrollment
3115
Registered
2017-12-26
Start date
2018-03-12
Completion date
2019-03-08
Last updated
2019-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resistance Bacterial

Brief summary

Antimicrobial resistance is one of the greatest threats to human health, and is driven by inappropriate antimicrobial use. Antimicrobial stewardship programs (ASPs) improve the use of antimicrobials in hospitals. The purpose of this study is to identify the need for and barriers to implementation of ASPs in three hospitals in Sri Lanka, Kenya, and Tanzania.

Detailed description

Antimicrobial resistance is one of the greatest threats to human health, and is driven by the inappropriate antimicrobial use. Antimicrobial stewardship programs (ASPs) improve the use of antimicrobials. The purpose of this study is to identify the need for and barriers to implementation of ASPs in three hospitals in Sri Lanka, Kenya, and Tanzania. The impact of creating a basic ASP will be assessed at each hospital.

Interventions

OTHERAntimicrobial stewardship advice

A basic antimicrobial stewardship team will be created at each site. The team will provide advice on the treatment of urinary tract infections and asymptomatic bacteriuria during the second half of the study.

Sponsors

Moi University
CollaboratorOTHER
Kilimanjaro Christian Medical Centre, Tanzania
CollaboratorOTHER
Ruhuna University, Sri Lanka
CollaboratorUNKNOWN
Duke University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

All patients admitted to the medical wards -

Exclusion criteria

None \-

Design outcomes

Primary

MeasureTime frameDescription
Appropriate antimicrobial use, for example for urinary syndromes6 monthsA composite outcome will be created for 'inappropriate' antibiotic use. This outcome will consist of 1) Unnecessary treatment for asymptomatic bacteriuria, 2) Inappropriate duration of therapy for urinary tract infection (UTI)/ cystitis/ pyelonephritis (binary outcome- yes/no), and 3) Unnecessary double coverage for UTI/ cystitis/ pyelonephritis (binary outcome- yes/no)

Countries

Sri Lanka

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026